Publications

Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites.

Fremeau RT, Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, Chaudhry FA, Nicoll RA, Edwards RH

2004
Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites.

Fremeau RT, Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, Chaudhry FA, Nicoll RA, Edwards RH

2004
In vivo characterization of the Nkx2.1 promoter/enhancer elements in transgenic mice.

Pan Q, Li C, Xiao J, Kimura S, Rubenstein J, Puelles L, Minoo P

2004
In vivo characterization of the Nkx2.1 promoter/enhancer elements in transgenic mice.

Pan Q, Li C, Xiao J, Kimura S, Rubenstein J, Puelles L, Minoo P

2004
Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.

Fernandez T, Morgan T, Davis N, Klin A, Morris A, Farhi A, Lifton RP, State MW

2004
Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.

Fernandez T, Morgan T, Davis N, Klin A, Morris A, Farhi A, Lifton RP, State MW

2004
Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa.

Akiyama H, Chaboissier MC, Behringer RR, Rowitch DH, Schedl A, Epstein JA, de Crombrugghe B

2004
Methods for high-density admixture mapping of disease genes.

Patterson N, Hattangadi N, Lane B, Lohmueller KE, Hafler DA, Oksenberg JR, Hauser SL, Smith MW, O'Brien SJ, Altshuler D, Daly MJ, Reich D

2004

Pages